{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T10:23:50Z","timestamp":1774607030940,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jaad.2020.11.055","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T11:08:21Z","timestamp":1606561701000},"page":"1597-1599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Evaluating the barriers to isotretinoin treatment for acne vulgaris in pediatric patients"],"prefix":"10.1016","volume":"85","author":[{"given":"Nidhi","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Yasmine","family":"Kirkorian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.jaad.2020.11.055_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0210445","article-title":"Differences in isotretinoin start, interruption, and early termination across race and sex in the iPLEDGE era","volume":"14","author":"Charrow","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.jaad.2020.11.055_bib2","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/jamadermatol.2019.4818","article-title":"Association of race\/ethnicity and sex with differences in health care use and treatment for acne","volume":"156","author":"Barbieri","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jaad.2020.11.055_bib3","article-title":"Isotretinoin and iPledge program patient information video: a new modality that improves patient comprehension","author":"Greywal","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.11.055_bib4","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/j.jaad.2020.01.014","article-title":"Relationship between sociodemographic factors and geographic distribution of pharmacies dispensing isotretinoin in Washington, DC","volume":"83","author":"Shah","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2020.11.055_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/jamadermatol.2015.4763","article-title":"Personal burden of isotretinoin therapy and willingness to pay for electronic follow-up visits","volume":"152","author":"Mori","year":"2016","journal-title":"JAMA Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220331042?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962220331042?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:01:58Z","timestamp":1759273318000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962220331042"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0190962220331042"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2020.11.055","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluating the barriers to isotretinoin treatment for acne vulgaris in pediatric patients","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2020.11.055","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}